-
EP3808367
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3808367
| EP3808367 - TARGETING ANEURYSM DISEASE BY MODULATING PHAGOCYTOSIS PATHWAYS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 01.02.2024 Database last updated on 03.09.2024 | |
| Former | Request for examination was made Status updated on 28.01.2022 | ||
| Former | The application has been published Status updated on 19.03.2021 | Most recent event Tooltip | 17.08.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038 / US | [2021/16] | Inventor(s) | 01 /
LEEPER, Nicholas J. 300 Pasteur Drive H3634 Stanford, CA 94305 / US | 02 /
WEISSMAN, Irving L. 747 Santa Ynez Street Stanford, CA 94305 / US | [2021/16] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2021/16] | Chapman, Desmond Mark Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | Application number, filing date | 20189471.4 | 09.09.2015 | [2021/16] | Priority number, date | US201462050664P | 15.09.2014 Original published format: US 201462050664 P | [2021/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP3808367 | Date: | 21.04.2021 | Language: | EN | [2021/16] | Type: | A3 Search report | No.: | EP3808367 | Date: | 21.07.2021 | Language: | EN | [2021/29] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.06.2021 | Classification | IPC: | A61K38/17, A61P9/10, C07K16/28, C12Q1/68 | [2021/16] | CPC: |
C07K16/2803 (EP,US);
A61K38/17 (EP,US);
A61P9/10 (EP,US);
C12Q1/6883 (EP,US);
A61K2039/505 (EP,US);
C07K2317/24 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/09] |
| Former [2021/16] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | ABZIELUNG AUF ANEURYSMA DURCH MODULATION VON PHAGOZYTOSESIGNALWEGEN | [2021/16] | English: | TARGETING ANEURYSM DISEASE BY MODULATING PHAGOCYTOSIS PATHWAYS | [2021/16] | French: | CIBLAGE D'UNE MALADIE ANÉVRISMALE PAR DES VOIES DE MODULATION DE LA PHAGOCYTOSE | [2021/16] | Examination procedure | 21.01.2022 | Amendment by applicant (claims and/or description) | 21.01.2022 | Examination requested [2022/09] | 21.01.2022 | Date on which the examining division has become responsible | 31.01.2024 | Despatch of a communication from the examining division (Time limit: M06) | 16.08.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Parent application(s) Tooltip | EP15841383.1 / EP3194024 | Fees paid | Renewal fee | 04.08.2020 | Renewal fee patent year 03 | 04.08.2020 | Renewal fee patent year 04 | 04.08.2020 | Renewal fee patent year 05 | 04.08.2020 | Renewal fee patent year 06 | 10.09.2021 | Renewal fee patent year 07 | 26.08.2022 | Renewal fee patent year 08 | 29.08.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||